<DOC>
	<DOCNO>NCT00561197</DOCNO>
	<brief_summary>This Phase 1/ 2 , open-label , single-center study preoperative chemoradiotherapy AT-101 patient locally advanced esophageal gastroesophageal junction cancer .</brief_summary>
	<brief_title>An Open-label , Single-center , Phase 1/ 2 Study Chemoradiotherapy AT-101 Patients With Locally Advanced Esophageal Gastroesophageal Junction Cancer</brief_title>
	<detailed_description />
	<mesh_term>Gossypol acetic acid</mesh_term>
	<mesh_term>Gossypol</mesh_term>
	<criteria>Male female patient age â‰¥18 year Histologically confirm primary ( nonrecurrent ) adenocarcinoma ( AC ) squamous cell carcinoma esophagus AC gastroesophageal ( GE ) junction . For Phase 1 : Phase 1 patient must unresectable disease ( Stage II IVa ) . A patient unresectable medical reason technical reason eligible chemoradiation . For Phase 2 : Phase 2 patient must resectable cancer define : T2 , T3 , N0 ; OR T13 , N+ Patients must archive tumor tissue correlate tumor biomarker expression clinical response . Availability tumor specimens paraffin block least two unstained slide must confirm prior study entry . Results use determine patient eligibility study . ECOG performance status 01 Adequate hematologic function Adequate liver renal function Ability swallow retain oral medication . Patients distant metastasis , include M1b lymph node status . ( M1b status allow Phase I patient appropriate chemoradation ) . Lymph nod suspicious M1b status diagnostic imaging must verify fineneedle aspiration cytology . ( Phase 2 ) For Phase 2 : Patients positive pleural , pericardial , peritoneal cytology . For Phase 2 : Patients carcinoma cervical esophagus . For Phase 2 : Patients clinical evidence metastasis cervical supraclavicular lymph node . Prior chemotherapy radiotherapy esophageal gastroesophageal junction cancer . Phase 1 patient prior chemotherapy permit enter . Prior radiotherapy would overlap anticipated study treatment field radiotherapy &gt; 30 % marrow cavity ( prior chest irradiation ) . Patients malabsorption syndrome , disease significantly affect gastrointestinal function , resection stomach small bowel exclude . Subjects ulcerative colitis , inflammatory bowel disease , partial complete small bowel obstruction also exclude . Pregnant nursing female . Fertile patient ( male female ) must use effective contraception .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>